DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
82.93
-0.65 (-0.78%)
At close: Jul 3, 2025, 1:00 PM
82.92
-0.01 (-0.01%)
After-hours: Jul 3, 2025, 4:37 PM EDT

DexCom Market Cap

DexCom has a market cap or net worth of $32.52 billion as of July 3, 2025. Its market cap has decreased by -29.83% in one year.

Market Cap
32.52B
Enterprise Value
32.40B
1-Year Change
-29.83%
Ranking
Category
Stock Price
$82.93

Market Cap Chart

Since April 14, 2005, DexCom's market cap has increased from $312.50M to $32.52B, an increase of 10,305.59%. That is a compound annual growth rate of 25.81%.

History

DateMarket Cap% Change
Jul 3, 202532.52B7.05%
Dec 31, 202430.38B-36.64%
Dec 29, 202347.95B9.61%
Dec 30, 202243.74B-15.95%
Dec 31, 202152.04B46.58%
Dec 31, 202035.50B77.33%
Dec 31, 201920.02B88.10%
Dec 31, 201810.64B113.41%
Dec 29, 20174.99B-1.16%
Dec 30, 20165.05B-24.21%
Dec 31, 20156.66B57.98%
Dec 31, 20144.21B65.82%
Dec 31, 20132.54B169.96%
Dec 31, 2012941.50M49.75%
Dec 30, 2011628.70M-21.59%
Dec 31, 2010801.80M115.77%
Dec 31, 2009371.60M352.07%
Dec 31, 200882.20M-67.11%
Dec 31, 2007249.90M-9.82%
Dec 29, 2006277.10M-26.81%
Dec 30, 2005378.60M21.15%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 306.47B
UnitedHealth Group 279.90B
Novartis AG 238.56B
Abbott Laboratories 233.90B
AstraZeneca 216.08B
Market Cap Rankings